|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 21-01-19 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 20-12-22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 2019-12-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 2001-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 2015-07-31 |
Sally L. Maher
BRD | Director/Board Member | - | 2019-04-30 |
| Director/Board Member | 71 | 2019-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| -1.52% | -2.51% | -17.70% | +5.78% | 191B | |
| +1.00% | +3.48% | +0.92% | +13.36% | 118B | |
| +0.26% | +4.98% | +14.26% | +92.74% | 64.19B | |
| +0.29% | +0.51% | +24.42% | +49.21% | 51.49B | |
| +0.05% | -0.27% | -1.05% | -32.62% | 51.08B | |
| +0.02% | +0.47% | +13.67% | -11.96% | 33.85B | |
| +0.80% | +5.60% | - | - | 31.85B | |
| +0.03% | -0.97% | +37.67% | -15.93% | 24.11B | |
| -1.32% | -4.10% | -7.26% | +12.11% | 22.96B | |
| Average | -0.04% | -0.18% | +8.12% | +14.08% | 58.9B | |
| Weighted average by Cap. | -0.24% | -0.79% | +0.09% | +16.14% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 76.77M 72.04M 65.91M 123M 8.43B 124M 852M 332M 4.31B 335M 328M 13.88B | 101M 86.72M 81.38M 74.46M 139M 9.53B 140M 963M 375M 4.87B 379M 370M 15.68B |
| Net income | -3.13M -2.69M -2.53M -2.31M -4.32M -296M -4.35M -29.91M -11.65M -151M -11.76M -11.5M -487M | 1.45M 1.25M 1.17M 1.07M 2M 137M 2.01M 13.84M 5.39M 69.99M 5.44M 5.32M 225M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
